Indomethacin/Levonorgestrel

吲哚美辛/左炔诺孕酮

Report date: 2025/04/28 22:35:30

Base Information

Drug NameIndomethacin/Levonorgestrel
Drug Alias Name左炔诺孕酮/吲哚美辛Indomethacin+LevonorgestrelLevonorgestrel/Indomethacin吲哚美辛+左炔诺孕酮Levonorgestrel+Indomethacin +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCyclooxygenases inhibitorsProgesterone receptor agonists
TargetsProgesterone receptorCyclooxygenases
Therapy Area/IndicationsContraception
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LevonorgestrelIndomethacin
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsContraception
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A